MeiraGTx Holdings (MGTX) Profit After Tax (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Profit After Tax came in at $17.7 million in Q4 2025, up 144.88% YoY from $7.2 million in Q4 2024, and up 135.86% on a QoQ basis from -$49.3 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Profit After Tax (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Profit After Tax data on file, last reported at $17.7 million in Q4 2025.
- Quarterly Profit After Tax rose 144.88% year-over-year to $17.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$110.4 million (up 25.3% YoY) and the FY2025 annual result came in at -$114.2 million, up 22.73% from the prior year.
- Profit After Tax advanced to $17.7 million in Q4 2025, from -$49.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $20.2 million in Q4 2023 to a low of -$49.3 million in Q3 2025.
- A 5-year average of -$27.7 million and a median of -$30.7 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 357.78% — and 2025, when it surged 144.88%.
- Tracing MGTX's Profit After Tax over 5 years: stood at -$9.9 million in 2021, then slumped by 357.78% to -$45.4 million in 2022, then surged by 144.55% to $20.2 million in 2023, then slumped by 294.9% to -$39.4 million in 2024, then surged by 144.88% to $17.7 million in 2025.
- The last three Profit After Tax figures came in at $17.7 million (Q4 2025), -$49.3 million (Q3 2025), and -$38.8 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.62 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 160.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.67 Mn |
| Dec 31, 2025 | 17.68 Mn |
| Sep 30, 2025 | -50.51 Mn |
| Jun 30, 2025 | -38.80 Mn |
| Mar 31, 2025 | -39.98 Mn |
| Dec 31, 2024 | -38.27 Mn |
| Sep 30, 2024 | -40.56 Mn |
| Jun 30, 2024 | -48.62 Mn |
| Mar 31, 2024 | -20.44 Mn |
| Dec 31, 2023 | 12.73 Mn |
| Sep 30, 2023 | -44.30 Mn |
| Jun 30, 2023 | -29.58 Mn |
| Mar 31, 2023 | -30.36 Mn |
| Dec 31, 2022 | -27.31 Mn |
| Sep 30, 2022 | -37.28 Mn |
| Jun 30, 2022 | -33.97 Mn |
| Mar 31, 2022 | -31.05 Mn |
| Dec 31, 2021 | -9.91 Mn |
| Sep 30, 2021 | -25.95 Mn |
| Jun 30, 2021 | -20.09 Mn |